A Holistic Approach to Sports Performance

[unable to retrieve full-text content] It’s not uncommon while watching world-class athletes glide effortlessly across fields, courts, tracks, and rinks, to wonder what it would take for us to do the same. As we know, these performances are far from effortless, and are the result of years of hard work in the field of play,… Read More »

FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for First-Line Treatment of NSCLC

Print this page KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC) who are not… Read More »